Delivery Order SPE2DB24D2101-SPE2DB25FKLER
- Not listed
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,477.57 for Lumigan 0.01% eye drops (7.5mL) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery of pharmaceutical products to support federal medical procurement needs. The work will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.22 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (2.5 mL) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $1,987.06 delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.12 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,768.84 to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops (5ml) on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops in 5mL quantities under a firm fixed price contract. The award, issued on August 19, 2025, carries a ceiling value of $2,108.68 with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a delivery order valued at $8,896.43 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes firm fixed price pricing with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,202.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561772066 Lumigan 0.01% eye drops. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order from August 10-11, 2023 is under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. As the prime and parent company, Amerisourcebergen Corporation will fulfill the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,616.96 to Amerisourcebergen Drug Corporation for the supply of 2.5ml Lumigan 0.01% eye drops. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 1...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLERDelivery Order
The Defense Logistics Agency awarded a $2,210.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5mL) on June 6, 2025, with an ultimate completion date of June 9, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that supports military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical supply requirements through open competition. This particular order for ophthalmic medication reflects the company's role in supplying specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare systems, consistent with its established position as a major federal pharmaceutical vendor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/6/25 |